The Division of Child and Adolescent Psychiatry is currently recruiting participants for the following research studies:
An Open-Label Extension Study of LUMINENZ-AT (CM-AT) in Children with Autism
Investigators at the University of Texas Health Science Center at Houston are conducting a 180-week clinical study to assess the long-term safety and effectiveness of an investigational medication (CM-AT/LUMINENZ-AT) designed to treat behavioral and gastrointestinal symptoms of autism in children. Your child may be eligible if he/she has a diagnosis of autism, is between 9 and 12 years old, and has a parent who can read and sign a consent form written in English. For more information, click here or contact Rosleen Mansour at 713-486-2591 or Rosleen Mansour@uth.tmc.edu.
We are currently recruiting children and adolescents with Autism Spectrum Disorders . This study will examine the cognitive and behavioral symptoms of children who have Autism Spectrum Disorders or ADHD and the effectiveness of methylphenidate in treating attention and behavior problems in children who have both Autism and ADHD symptoms. Click here for more information.
Participants may also join our Research Registry and we will contact them for future studies. You may join by:
with comments or suggestions.